Cargando…
A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
The aim of this study was to find a procedure allowing estimation of individual pharmacokinetic parameters for adriamycin with minimal cost and disturbance for the patient. Twenty-five patients with breast cancer were treated by short infusion of adriamycin at a dose of 12 mg m-2 week-1 (41 courses)...
Autores principales: | Launay, M. C., Milano, G., Iliadis, A., Frenay, M., Namer, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247334/ https://www.ncbi.nlm.nih.gov/pubmed/2803920 |
Ejemplares similares
-
Tamoxifen metabolism: pharmacokinetic and in vitro study.
por: Etienne, M. C., et al.
Publicado: (1989) -
Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986) -
Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.
por: Kerr, D. J., et al.
Publicado: (1988) -
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions
por: de Rouw, Nikki, et al.
Publicado: (2019) -
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.
por: Gabizon, A., et al.
Publicado: (1991)